Numerous publications have provided evidence that the STAT3 gene produces oncogenic effects in a variety of cancers, including being active in 50–60% of primary breast tumours and being linked to the promotion of breast cancer stem cell traits [51, 52]. The gene discussed is STAT3; the disease is breast neoplasm.